Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03648983 · ClinicalTrials.gov registry record · NA
Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer
A NA study, sponsored by Albert Einstein College of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT03648983 is a NA study that was terminated before completion, run by Albert Einstein College of Medicine. The registered enrollment target is 95 participants.
The verdict
NCT03648983, a NA study, was terminated before completion, sponsored by Albert Einstein College of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies arm circumference measurement with or without bioimpedance spectroscopy in finding extra lymph node fluid build up in the arm (lymphedema) early in patients with stage I-III breast cancer undergoing lymph node dissection or sentinel node biopsy. Diagnostic procedures, such as bioimpedance spectroscopy, may allow doctors to find and diagnose lymphedema earlier than arm circumference measurement alone.
Interventions
- PROCEDURE arm circumference measurement
- DEVICE Bioimpedance spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2011-11 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03648983
The ClinicalTrials.gov registry entry for NCT03648983 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which arm circumference measurement is the first listed.
NCT03648983 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03648983 about?
NCT03648983 is a clinical study titled "Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer". This randomized pilot clinical trial studies arm circumference measurement with or without bioimpedance spectroscopy in finding extra lymph node fluid build up in the arm (lymphedema) early in patients with stage I-III breast cancer undergoing lymph node dissection or sentinel node biopsy. Diagnosti...
What is the current status of trial NCT03648983?
This trial is currently terminated. It is a NA study. The enrollment target is 95 participants. The study started on 2011-11. Estimated completion is 2015-08.
What interventions are being tested in trial NCT03648983?
The interventions under investigation include: arm circumference measurement (PROCEDURE), Bioimpedance spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT03648983?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.